a Therapeutics(COYA) - 2023 Q1 - Quarterly Report

Securities registered pursuant to Section 12(b) of the Act: COYA THERAPEUTICS, INC. CONDENSED BALANCE SHEETS Coya Therapeutics, Inc. (Exact Name of Registrant as Specified in its Charter) 2 | --- | --- | --- | --- | --- | |--------------------------------------------------------------------------------------------------|-------|-------------------------|-------|--------------------| | Cash flows from operating activities: | | Three Months \n2023 | Ended | March 31, \n2022 | | Net loss | $| (2,736,462 ) |$ ...